Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
30.13
+2.07 (7.38%)
Nov 10, 2025, 3:47 PM EST - Market open
Enovis Revenue
Enovis had revenue of $548.91M in the quarter ending October 3, 2025, with 8.65% growth. This brings the company's revenue in the last twelve months to $2.23B, up 11.57% year-over-year. In the year 2024, Enovis had annual revenue of $2.11B with 23.46% growth.
Revenue (ttm)
$2.23B
Revenue Growth
+11.57%
P/S Ratio
0.71
Revenue / Employee
$303,145
Employees
7,367
Market Cap
1.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.11B | 400.43M | 23.46% |
| Dec 31, 2023 | 1.71B | 144.10M | 9.22% |
| Dec 31, 2022 | 1.56B | 136.91M | 9.60% |
| Dec 31, 2021 | 1.43B | 305.49M | 27.26% |
| Dec 31, 2020 | 1.12B | -2.21B | -66.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ENOV News
- 3 days ago - Enovis Corporation (ENOV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Enovis Announces Third Quarter 2025 Results - GlobeNewsWire
- 17 days ago - Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences - GlobeNewsWire
- 4 weeks ago - Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million - GlobeNewsWire
- 2 months ago - Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Enovis: Healthy Recon Trends Vs. Market Apathy - Seeking Alpha
- 3 months ago - Enovis to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Enovis Corporation (ENOV) Q2 2025 Earnings Call Transcript - Seeking Alpha